SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Motilal Oswal Recommends Buying Emcure Pharmaceuticals, Sets Rs 2,330 Target

Motilal Oswal cited recovery in Emcure’s domestic formulation segment, led by gynecology, anti-infectives, cardiac and anti-diabetic products, and strong growth in key brands.

EMCURE

Related stories